Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Molecular Biology of the Cell|June 12, 2002
Identification of genes periodically expressed in the human cell cycle and their expression in tumorsMichael L Whitfield, Gavin Sherlock, Alok J Saldanha, et al.
The Plant Journal : for Cell and Molecular Biology|April 30, 2020
Genotypic and phenotypic characterization of a large, diverse population of maize near-isogenic linesLaura Morales, A C Repka, Kelly L Swarts, et al.
Neoplasia (New York, N.Y.)|May 31, 2016
IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor RecurrenceKelsey A Finkel, Kristy A Warner, Samuel Kerk, et al.
Nature Genetics|January 11, 2011
Genome-wide association study of quantitative resistance to southern leaf blight in the maize nested association mapping populationKristen L Kump, Peter J Bradbury, Randall J Wisser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell CarcinomaSamuel A Kerk, Kelsey A Finkel, Alexander T Pearson, et al.
Plos Genetics|August 29, 2014
A genome-wide association study of the maize hypersensitive defense response identifies genes that cluster in related pathwaysBode A Olukolu, Guan-Feng Wang, Vijay Vontimitta, et al.
The Journal of Clinical Investigation|January 17, 2018
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regressionHeng Lin, Shuang Wei, Elaine M Hurt, et al.
Immunity|September 4, 2004
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiationA L Shaffer, Miriam Shapiro-Shelef, Neal N Iwakoshi, et al.
Genome Biology|October 13, 2001
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridolL T Lam, O K Pickeral, A C Peng, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Pageof 21